Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells

被引：64

作者：

Amirsaadat, Soumaye ^{[1
]}

Pilehvar-Soltanahmadi, Younes ^{[1
]}

Zarghami, Faraz ^{[1
]}

Alipour, Shahriar ^{[2
]}

Ebrahimnezhad, Zohreh ^{[1
]}

Zarghami, Nosratollah ^{[1
]}

机构：

[1] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz, Iran

[2] Tabriz Univ Med Sci, Fac Adv Med Sci, Mol Med, Tabriz, Iran

来源：

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 2017年 / 45卷 / 08期

关键词：

Silibinin; (FeO4)-O-3; PLGA-PEG; A549; hTERT; TELOMERASE ACTIVITY; BREAST-CANCER; IN-VITRO; DRUG-DELIVERY; PLGA; BIODISTRIBUTION; DEGRADATION; GROWTH; MICE; LINE;

D O I：

10.1080/21691401.2016.1276922

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Nanoparticle-based targeted drug delivery has the potential for rendering silibinin specifically at the favorite site using an external magnetic field. Also, it can circumvent the pitfalls of poor solubility. For this purpose, silibinin-loaded magnetic nanoparticles are fabricated, characterized and evaluated cytotoxicity and hTERT gene expression in A549 lung cancer cell line. silibinin-loaded PLGA-PEG-Fe3O4 had dose- and time-dependent cytotoxicity than pure silibinin. Additionally, hTERT expression is more efficiently reduced with increasing concentrations of nanosilibinin than pure silibinin. The present study indicates that PLGA-PEG-Fe3O4 nanoparticles, as an effective targeted carrier, can make a promising horizon in targeted lung cancer therapy.

引用

页码：1649 / 1656

页数：8

共 33 条

[1] An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity [J].

Alibakhshi, Abbas ;

Ranjbari, Javad ;

Pilehvar-Soltanahmadi, Yones ;

Nasiri, Marzieh ;

Mollazade, Mahdie ;

Zarghami, Nosratollah .

CURRENT MEDICINAL CHEMISTRY, 2016, 23 (22) :2380-2393

[2]

[Anonymous], J NANOSTRUCT CHEM

[3] PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].

Avgoustakis, K ;

Beletsi, A ;

Panagi, Z ;

Klepetsanis, P ;

Karydas, AG ;

Ithakissios, DS .

JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135

[4] Comparison between Effects of Free Curcumin and Curcumin Loaded NIPAAm-MAA Nanoparticles on Telomerase and PinX1 Gene Expression in Lung Cancer Cells [J].

Badrzadeh, Fariba ;

Akbarzadeh, Abolfazl ;

Zarghami, Nosratollah ;

Yamchi, Mohammad Rahmati ;

Zeighamian, Vahide ;

Tabatabae, Fateme Sadate ;

Taheri, Morteza ;

Kafil, Hossein Samadi .

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (20) :8931-8936

[5] Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers [J].

Beletsi, A ;

Panagi, Z ;

Avgoustakis, K .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 298 (01) :233-241

[6]

Bodnar A, 1997, NAT GENET, V17, P502

[7] Hierarchically nanostructured magnetic hollow spheres of Fe3O4 and γ-Fe2O3:: Preparation and potential application in drug delivery [J].

Cao, Shao-Wen ;

Zhu, Ying-Jie ;

Ma, Ming-Yan ;

Li, Liang ;

Zhang, Ling .

JOURNAL OF PHYSICAL CHEMISTRY C, 2008, 112 (06) :1851-1856

[8] Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer [J].

Deep, Gagan ;

Agarwal, Rajesh .

CANCER AND METASTASIS REVIEWS, 2010, 29 (03) :447-463

[9] Magnetic nanoparticles for drug delivery [J].

Dobson, J .

DRUG DEVELOPMENT RESEARCH, 2006, 67 (01) :55-60

[10] Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin [J].

Dube, Devyani ;

Khatri, Kapil ;

Goyal, Amit K. ;

Mishra, Neeraj ;

Vyas, Suresh P. .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (05) :547-555

← 1 2 3 4 →